文献速递瓣膜外科先天性心脏病外科

儿童二尖瓣置换:机械瓣与生物瓣的耐久性与风险比较

Mitral valve replacement in children: balancing durability and risk with mechanical and bioprosthetic valves.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该研究回顾1981至2020年儿童二尖瓣置换病例,将生物瓣与机械瓣个体匹配各28例。生物瓣7年二次置换累积发生率63.6%,机械瓣7年10.7%、15年41.1%;免移植生存两组无差异。生物瓣寿命受钙化所致结构衰败限制,机械瓣15年后约40%因躯体生长相关患者-人工瓣不匹配而置换。

要点

  • 生物瓣与机械瓣二尖瓣置换后免移植生存无统计学差异(P=0.33)。
  • 生物瓣7年二次置换累积发生率63.6%,机械瓣7年10.7%、15年41.1%。
  • 机械瓣15年后约40%因躯体生长相关患者-人工瓣不匹配而置换。

核心结论

  • 儿童生物瓣与机械瓣二尖瓣置换后免移植生存无差异。
  • 生物瓣寿命受钙化所致结构衰败限制。
  • 机械瓣15年后约40%因躯体生长相关患者-人工瓣不匹配而置换。

研究设计与样本

  • 回顾性分析1981至2020年儿童二尖瓣置换病例。
  • 生物瓣组28例与机械瓣组28例进行个体匹配。
  • 二次置换累积发生率采用考虑死亡或移植为竞争风险的累积发生函数计算。

主要发现

  • 生物瓣组植入中位年龄3.6岁(四分位距0.8-7.9),机械瓣组3岁(四分位距1.3-7.8)。
  • 生物瓣置换后7年死亡或移植累积发生率17.9%(95%CI 6.3-34.1),二次置换累积发生率63.6%(95%CI 39.9-80.1)。
  • 机械瓣置换后7年死亡或移植累积发生率28.6%(95%CI 13.3-46),二次置换累积发生率10.7%(95%CI 2.6-25.5)。
  • 机械瓣置换后15年死亡或移植累积发生率33.6%(95%CI 16.2-52.1),二次置换累积发生率41.1%(95%CI 18.4-62.7)。
  • 二次置换累积发生率曲线两组间有统计学差异(P<0.001),死亡或移植曲线无统计学差异(P=0.33)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate if there is still a place for bioprosthetic mitral valve replacement in children by comparing the prosthetic durability and transplant-free survival after bioprosthetic and mechanical mitral valve replacement. METHODS: We reviewed all mitral valve replacements in children between 1981 and 2020. Bioprosthetic mitral valve replacement cases were individually matched to mechanical mitral valve replacement cases. The incidence rate of a 2nd replacement was calculated using the cumulative incidence function that considered death or transplantation as a competing risk. RESULTS: The median age at implantation was 3.6 years (interquartile range 0.8-7.9) for the bioprosthetic valve cohort (n = 28) and 3 years (interquartile range 1.3-7.8) for the mechanical valve cohort (n = 28). Seven years after bioprosthetic mitral valve replacement, the cumulative incidence of death or transplantation was 17.9% [95% confidence interval (CI) 6.3-34.1] and the cumulative incidence of a 2nd replacement was 63.6% (95% CI 39.9-80.1). Seven years after mechanical mitral valve replacement, the cumulative incidence of death or transplantation was 28.6% (95% CI 13.3-46) and the cumulative incidence of a 2nd replacement was 10.7% (95% CI 2.6-25.5). Fifteen years after mechanical mitral valve replacement, the cumulative incidence of death or transplantation was 33.6% (95% CI 16.2-52.1) and the cumulative incidence of a 2nd replacement was 41.1% (95% CI 18.4-62.7). The cumulative incidence curves for bioprosthetic and mechanical mitral valve replacement were statistically different for a 2nd valve replacement (P < 0.001) but not for death or transplantation (P = 0.33). CONCLUSIONS: There is no difference in transplant-free survival after bioprosthetic and mechanical mitral valve replacement in children. The lifespan of bioprosthetic mitral valves remains limited in children because of structural valve failure due to calcification. After 15 years, 40% of mechanical valves were replaced, primarily because of patient-prosthesis mismatch related to somatic growth.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Van Puyvelde J, Meyns B, Rega F, et al. Mitral valve replacement in children: balancing durability and risk with mechanical and bioprosthetic valves. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38447197. doi:10.1093/icvts/ivae034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。